ESH eLearning

WELCOME
Welcome to the ESH eLearning Centre!
  • Our goal is to share knowledge regarding the world of haematology.
  • With our conferences, we connect professionals all around the world.
  • With this platform, we allow everyone to relive the talks and discussions of our events for free!

Welcome to the ESH eLearning Centre!

ESH believes it is very important to allow specialists to gain new knowledge, competencies, and skills or to brush up on acquired ones at a time and place of their choosing.
 

The ESH eLearning platform comprises freely accessible:

→ on-demand components from ESH Conferences (slide bank, video presentations/ webcast, and discussions) ; whether you cannot attend live events because of time, mobility, financial or other restraints, or you simply wish to review content presented at a session you attended

→ as well as quizzes, learning tools, interviews, abstracts, documents and articles.
 

Stay updated:

→ Sign up for ESH Newsletter

→ Follow us on ESH social media (X, Facebook, LinkedIn)
UPCOMING CONFERENCES
ESH upcoming conferences
  • September 26-28, 2025: 3rd How I Manage CAR-T Therapies and Bispecific Antibodies for my Patients
  • October 02-04, 2025: 8th Translational Research Conference Lymphoid Malignancies
  • October 10-12, 2025: ESH-iCMLf 27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy
  • Click on "learn more" to access the full ESH upcoming conference agenda

ESH provides a diverse portfolio of leading-edge scientific, translational research and clinically oriented meetings at which outstanding international faculties actively inform, mentor and interact face to face with practicing biologists and clinicians from across the world.  

→ Ample time is deliberately provided for in-depth scientific discussion and interaction. 

→ Registered participants further benefit from a variety of opportunities for informal scientific interaction with the world’s leading experts in their field, including during small Meet the Expert sessions and Mentored Posters Walks.

→ ESH conference delegates are invited to submit abstracts. Selected abstracts are presented as brief oral communications or posters.

 

ESH upcoming conferences agenda comprises:

- Scientific Workshops: 

→ organized in rapidly evolving scientific fields
 

- Translational Research Conferences:

→ disease-specific
→  focus on leading-edge basic, clinical and therapeutic research and future perspectives. 

→ the presentation of unpublished data is encouraged.
 

- “How to Diagnose and Treat” Conferences:

→ disease-specific
→ emphasize clinical management, including future perspectives

→ use case-based lectures to stimulate interaction
SPECIFIC DISEASES
Browse content by your topic(s) of interest
  • Leukaemias
  • Myelomas
  • Immune therapies and others…
STAY TUNED
OPEN CONTENT
  • Find all our open content without logging-in
4th Translational Research Conference: Acute Lymphoblastic Leukaemia
4th Translational Research Conference: Acute Lymphoblastic Leukaemia
  • Chairs : Kathrin Bernt, Jan Cools, Hervé Dombret, Ulla Wartiovaara-Kautto
  • May 22-24, 2025

On-demand content reserved to participants for a duration of 3 months after the conference, available to all from August 24th, 2025!

MAIN SCIENTIFIC TOPICS:
 

• The biology of T-ALL
• The biology of B-cell precursor ALL subtypes
• Specific genetic entities
• Host factors
• Measurable Residual Disease (MRD)
• Targeted therapy
• Immunotherapy
• Cell therapy
• Other potential ALL targets

FACULTY MEMBERS:

Smita BHATIA (Birmingham), Tina BHATLA (Newark), Nicolas BOISSEL (Paris), Monika BRÜGGEMANN (Kiel), Sabina CHIARETTI (Rome), Emmanuelle CLAPPIER (Paris), Jan COOLS (Leuven), Monique DEN BOER (Utrecht), Hervé DOMBRET (Paris), Rong FAN (New Haven), Sara GHORASHIAN (London), Nicola GÖKBUGET (Frankfurt), Ilaria IACOBUCCI (Memphis), Christian KRATZ (Hannover), James LABELLE (Chicago), Marc R. MANSOUR (London), Charles MULLIGHAN (Memphis), Triona NI-CHONGHAILE (Dublin), Rayne H. ROUCE (Houston), Philippe ROUSSELOT (Versailles), Lisa RUSSELL (Newcastle), Takaomi SANDA (Nagoya), Owen P. SMITH (Dublin), Izidor SOSIC (Ljubljana), Sarah K. TASIAN (Utrecht), David T. TEACHEY (Philadelphia), Ulla WARTIOVAARA-KAUTTO (Helsinki), Jun J. YANG (Memphis)​

ABOUT THE CONFERENCE:

ESH Translational Research Conference programmes are designed to place emphasis on lleading-edge basic, clinical and therapeutic research and future perspectives. Ample time is deliberately provided for in-depth scientific discussion and interaction. Registered participants further benefit from a variety of opportunities for informal scientific interaction with the world’s leading experts in their field, including during small Meet the Expert sessions and Mentored Posters Walks. ESH conference delegates are invited to submit abstracts. Selected abstracts are presented as brief oral communications or posters.

 
8thTranslational Research Conference on MULTIPLE MYELOMA
5th How to Diagnose and Treat: Multiple Myeloma
  • Chairs: Hermann Einsele, Maria Theresa Krauth, Maria-Victoria Mateos, Omar Nadeem
  • April 3-5, 2025 – Vienna, Austria

On-demand content reserved to participants for a duration of 3 months after the conference, available to all from July 3rd.

THE MAIN SCIENTIFIC TOPICS:

– How I treat smoldering myeloma (SMM)
– How I treat newly diagnosed multiple myeloma
– From risk stratification to risk-based therapy?
– Should we use MRD testing to determine therapy in multiple myeloma?
– Is CAR T cell therapy replacing autologous SCT?
– How I treat relapsed multiple myeloma
– Cell free DNA / circulating tumor cells to replace BM-biopsy and MRD measurement
– You can’t be immune for immune therapy anymore
– The future of multiple myeloma
– Other plasma cell dyscrasias

FACULTY MEMBERS:

Hermine Agis (Vienna), Kenneth C. Anderson (Boston), Nizar Bahlis (Calgary), Claudio Cerchione (Bologna), Sophia Danhof (Würzburg), Michel Delforge (Leuven), Hermann Einsele (Würzburg), Monika Engelhardt (Freiburg), Francesca Gay (Turin), Irene Ghobrial (Boston), Siobhan Glavey (Dublin), Hartmut Goldschmidt (Heidelberg), Roman Hajek (Ostrava), Martin Kaiser (London), Martin Kortüm (Würzburg), Maria Krauth (Vienna), Alessandra Larocca (Turin), Heinz Ludwig (Vienna), Omar Nadeem (Boston), Paola Neri (Calgary), Mario Nuvolone (Pavia), Elizabeth O'Donnell (Boston), Charlotte Pawlyn (London), Klaus Podar (Vienna), Rakesh Popat (London), Noemi Puig (Salamanca), Marc Raab (Heidelberg), Leo Rasche (Würzburg), Adam Sperling (Boston), Paula Tabares (Würzburg), Steven Treon (Boston), Niels Van de Donk (Amsterdam), Wolfgang Willenbacher (Innsbruck), Elena Zamagni (Bologna), Niklas Zojer (Vienna).

ABOUT THE CONFERENCE:
ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management.
They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase scientific interaction.
4th Translational Research Conference: Pathophysiology and Clinical Advances in Sickle Cell Disease and Thalassemia
4th Translational Research Conference: Pathophysiology and Clinical Advances in Sickle Cell Disease and Thalassemia
  • Chairs: Maria Domenica Cappellini, Michaela Fontenay, Alexis A. Thompson
  • March 14-16, 2025 - Malahide (Dublin), Ireland

On-demand programme freely available after login.

SCIENTIFIC TOPICS:

– Update on pathophysiology on sickle cell disease, thalassemia and normal red blood cell
– Iron and erythropoiesis
– Inflammation in sickle cell disease
– Dyserythopoiesis in thalassemia
– Premature aging in sickle cell and thalassemia
– Fetal hemoglobin control
– Novel pharmacologic approaches to sickle cell disease and thalassemia
– Novel genomic approaches to sickle cell and thalassemia
– Cases discussions

Faculty Members:

Annamaria APRILE (Milan), Valentina BOLLATI (Milan), Laura BREDA (Philadelphia), Maria-Domenica CAPPELLINI (Milan), Simona COLLA (Houston), Raffaella COLOMBATTI (Padova), Lucia DE FRANCESCHI (Verona), Marianne DE MONTALAMBERT (Paris), Sara EL HOSS (Paris), Perla ELEFTHERIOU (London),
Michaela FONTENAY (Paris), Olivier HERMINE (Paris), Theodosia KALFA (Cincinnati), Antonis KATTAMIS (Athens), Léon KAUTZ (Toulouse), Kevin KUO (Toronto), Franco LOCATELLI (Rome), Corrina McMAHON (Dublin), Martina MUCKENTHALER (Heidelberg), Mohandas NARLA (New York), Raffaella ORIGA (Cagliari), Stuart ORKIN (Boston), John PORTER (London), Stefano RIVELLA (Philadelphia), Antonella RONCHI (Milan), Lubka T. ROUMENINA (Paris), Laura SILVESTRI (Milan), Ali TAHER (Beirut), Alexis A. THOMPSON (Philadelphia), Francesca VINCHI (New York), Jian XU (Dallas).

 
4th How to Diagnose and Treat: CML/MPN
4th How to Diagnose and Treat: CML/MPN
  • Chairs : Claire Harrison, Andreas Hochhaus, Ruben Mesa
  • March 7-9, 2025 – Vienna, Austria

On-demand programme freely available after login.
 

MAIN SCIENTIFIC TOPICS:

• MPN – ABC of standard care

• MPN – Challenging clinical scenarios

• MPN Management

• CML – Risk assessment

• CML – Challenging clinical scenarios

• CML – Treatment optimization

• CML & MPN – Long term complications

• CML & MPN – What is on the horizon?

 

 

FACULTY MEMBERS:

Elisabetta Abruzzese (Rome), Tiziano Barbui (Bergamo), Massimo Breccia (Rome), Tim Brümmendorf (Aachen), Fausto Castagnetti (Bologna), Mhairi Copland (Glasgow), Jorge Cortes (Augusta), Fabio Efficace (Rome), Thomas Ernst (Jena), Valentin Garcia-Gutierrez (Madrid), Anna Godfrey (Cambridge), Martin Griesshammer (Minden), Paola Guglielmelli (Florence), Torsten Haferlach (Munich), Oliver Hantschel (Marburg), Claire Harrison (London), Andreas Hochhaus (Jena), Tim Hughes (Adelaide), Jean-Jacques Kiladjian (Paris), Andrew Kuykendall (Tampa), Philipp Le Coutre (Berlin), Danijela Lekovic (Belgrade), Katerina Machova (Prague), François Mahon (Bordeaux), Adam Mead (Oxford), Ruben Mesa (Winston Salem), Dragana Milojkovic (London), Francesco Passamonti (Milan), Deepti Radia (London), Delphine Rea (Paris), Andreas Reiter (Mannheim), David Ross (Adelaide), Giusseppe Saglio (Turin), Susanne Saussele (Mannheim), Daniel Wiseman (Manchester), Claire Woodley (London), Daniela Zackova (Brno).

ABOUT THE CONFERENCE:

ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management. They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase scientific interaction.

Building on the success of our 3 previous meetings, the programme for this clinically orientated meeting will allow the attendee to be immersed in the most up-to-date information for practical management of both common and rarer scenarios across the spectrum of CML and MPN and related conditions.

Our faculty is a host of international experts who will focus their interactions around difficult clinical scenarios and there will also be a variety of case-based discussions and debates.

 
5th Scientific Workshop: the Haematological Tumour Microenvironment and Its Therapeutic Targeting
5th Scientific Workshop: the Haematological Tumour Microenvironment and its Therapeutic Targeting
  • Chairs : Dominique Bonnet, Nitin Jain, Marina Konopleva, Daniela S. Krause, Simon Mendez-Ferrer, Kwee Yong
  • February 16-18, 2025 - London, United Kingdom

On-demand programme freely available after login.

SCIENTIFIC TOPICS

- Normal hematopoietic stem cell niche
- Stress and inflammation
- Clonal hematopoiesis
- The niche in myeloid malignancies
- The niche in lymphoid malignancies
- Solid tumour and microenvironment
- Clinical translation
 

 

 

​FACULTY MEMBERS:

Ioannis Aifantis (New York), Dominique Bonnet (London), Tobias Bopp (Mainz), Mihaela Crisan (Edinburgh), M. Carolina Florian (Barcelona), Gonia Gozdecka (Cambridge), Nitin Jain (Houston), Darja Karpova (Frankfurt), Katherine King (Houston), Bong-Ihn Koh (Münster), Marina Konopleva (New York), Daniela S. Krause (Mainz), Ilaria Malanchi (London), Jose A. Martinez-Climent (Pamplona), Simon Mendez-Ferrer (Cambridge), Sean Morrison (Dallas), Sattva S. Neelapu (Houston), Cesar Nombela Arrieta (Zurich), Simona Parrinello (London), Marc Raaijmakers (Rotterdam), Alan Ramsay (London), Ingo Ringshausen (London), Stuart Rushworth (Norwich), Jean-Emmanuel Sarry (Toulouse), Rebekka Schneider (Rotterdam), Paresh Vyas (Oxford), Kwee Yong (London)

​ABOUT THE WORKSHOP:

This workshop offers highest-level science on the nature of the normal and malignant haemopoietic stem cell niche. It also aims to present strategies to target haematological cancers in their tumour microenvironment, thereby combining basic research efforts with possible clinical applications. It is designed to promote scientific interaction between participants from all over the world, involving junior and senior biologists and clinicians working in both the academic and industrial settings.

 
We found no results for your search. Please change or remove at least one filter to broaden your search.
eLearning Centre supported by:

What's new

#ESHLYMPHOID2025: ONLY 2 WEEKS LEFT TO SUBMIT YOUR ABSTRACT!
8th Translational Research Conference
LYMPHOID MALIGNANCIES
October 2-4, 2025 – Estoril, Portugal
Chairs: Michael Hallek, Georg Lenz, Laurie Sehn, Louis Staudt, Catherine Wu

#ESHCART2025: REGISTRATION & ABSTRACT SUBMISSION ARE OPEN!
Proceed now and join us on 10th October in Estoril, Portugal!
3rd How I Manage
CAR-T Therapies and Bispecific Antibodies for my Patients
26 - 28 September , 2025 Chairs: Caron Jacobson, Ulrich Jäger, Marie José Kersten

#ESHMICRO2025: THE ON-DEMAND VIDEOS & PRESENTATIONS ARE FREELY AVAILABLE ON THE ESH eLEARNING CENTRE!
5th Scientific Workshop
The Haematological Tumour Microenvironment & its Therapeutic Targeting
Chairs: Dominique Bonnet, Nitin Jain, Marina Konopleva, Daniela Krause, Simón Méndez Ferrer and Kwee Yong

2025 ©
EUROPEAN SCHOOL OF HAEMATOLOGY
USER TERMS AND CONDITIONS / PRIVACY POLICY
(Amended according to GDPR)

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies